Home
|
Survey
|
Payment
|
Talks & Presentations
|
Job Opportunities
Journals
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Shanghai Medical and Pharmaceutical Journal
1006-1533
2013 Issue 21
ren ji xiao hua de yi shuang zuo xin huo xiang chuan
..............
page:1-2
The classiifcation and pharmacological characteristics of proton pump inhibitors
CHEN Jian
..............
page:3-7
quan guo zui da de zhong da ji bing zi yuan ku jian cheng yi na ru 5 wan yu li bing li
zhai zi jian kang bao
..............
page:7-7
The current views focused on clinical application of proton pump inhibitors
LI Wenting;CHEN Shengliang
..............
page:8-11,12
The potential safety issues related to long-term use of proton pump inhibitors
TANG Yuming
..............
page:12-15
shang hai zi mao qu jiang yin jin wai zi yi liao ji gou
zhai zi jian kang bao
..............
page:15-15
Interaction of clopidogrel and proton pump inhibitors
JIANG Weiru;ZHONG Liang
..............
page:16-19
Research progress of novel proton pump inhibitors
CHEN Jian;JIANG Weiru
..............
page:20-23
2013 shang hai zhong yi yao yu tian ran yao wu guo ji da hui cheng gong ju ban
2013 shang hai zhong yi yao yu tian ran yao wu guo ji da hui zu wei hui
..............
page:23-23
Clinical analysis of zoledronic acid in the treatment of 24 cases of osteoporosis
WANG Xia
..............
page:24-25,30
The common problems and the solutions of the phaseⅡclinical trial of recombinant human interferonα-2b injection
WANG Xiaoli
..............
page:26-30
The signiifcance of urinary microalbuminuria for diagnosis of early renal impairment occurred in the very elderly with essential hypertension in the community
XU Ming;LIU Xujiang
..............
page:31-33
zhong yang cai zheng xia bo 22 yi zhu tui jian kang yang lao ye
zhai zi shang hai zheng quan bao
..............
page:33-33
Clinical analysis of 45 cases of youth with gastric cancer
CHEN Fuyuan;XU Chunfang
..............
page:34-35
wo guo jiang kai zhan di si ci zhong yao zi yuan pu cha
zhai zi ren min ri bao
..............
page:35-35
2013 nian shang ban nian 22 di qu yang ben yi yuan yong yao zong ti fen xi
gan rong fu
..............
page:36-40
fu xing yi yao xie shou sellas tui dong zhong guo xin yao zou chu guo men
fu xing yi yao
..............
page:40-40
Exploration and optimization of drug management in operating room in Jiading central hospital
ZHANG Jingyin
..............
page:41-43
Study on the post-marketing aggregate reports in the United States
SUN Xinxin
..............
page:44-47
zhong guo zi zhu yan fa de yi miao shou ci huo shi jie wei sheng zu zhi yu ren zheng
zhai zi xin hua wang
..............
page:47-47
Preparation of azithromycin dispersible tablets
TAN Yueyao;LIN Youmiao
..............
page:48-50,53
Preparation and in vitro evaluation of multi-unit tablets of delayed release aspirin
LIU Wenli;HAN Hailing;HAN Jiansheng
..............
page:51-53
The investigation of bacterial identiifcation system based on numerical method
ZHU Minying;SONG Zhinan
..............
page:54-57
yao pin bu liang fan ying xin xi tong bao jing ti bie zuo chun pian yin qi de zhong zheng yao zhen
zhai zi cfda wang zhan
..............
page:58-60
fda pi zhun a wei mo zuo yong yu shu hou jia su hui fu wei chang dao gong neng de xin shi ying zheng
zhai zi ding xiang yuan
..............
page:60-61
2013 nian 9 yue fda pi zhun xin yao gai kuang
..............
page:60-60
fda pi zhun ma xi ti tan yong yu zhi liao fei dong mai gao ya
zhai zi ding xiang yuan
..............
page:61-62
nuo he nuo de qi xia xue you bing yao wu novoeight huo fda pi zhun
zhai zi ding xiang yuan
..............
page:61-61
luo shi ra yao wu actemra huo jia na da pi zhun yong yu er tong
zhai zi sheng wu gu
..............
page:62-62
luo shi perjeta cheng wei fda pi zhun de shou ge xin fu zhu liao fa
zhai zi sheng wu gu
..............
page:62-62
yi xue ji xu jiao yu da ti
..............
page:63-63